Surgical treatment of septic deep venous thrombosis. 1995

H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
Department of Anesthesiology, Heinrich-Heine-University Düsseldorf, Germany.

BACKGROUND Septic deep venous thrombosis (SDVT) is an uncommon but occasionally lethal disease caused by systemic complications. In most cases reported in the literature SDVT is caused by intravenous drug abuse or transvenous catheter lines. Conservative management with antibiotic drugs and systemic anticoagulation is usually successful, and the surgical approach is regarded as not indicated or unnecessary. Occasionally, however, conservative management fails, thrombosis progresses, and septic embolism develops. METHODS In a 7-year period five patients (three male and two female; mean age, 21.2 years), three with severe systemic complications of SDVT (femoropopliteal, 1; iliofemoral, 1; iliofemoral+vena cava, 3), were treated by venous thrombectomy in addition to intravenous antibiotic administration. Simultaneous transabdominal caval thrombectomy was performed twice. RESULTS Two patients suffered from respiratory failure caused by previous septic embolization. One patient had experienced multiorgan failure before thrombectomy was performed. Intensive care was necessary for all patients (mean, 28 days). All patients survived. CONCLUSIONS In complicated cases of SDVT without improvement or even impairment after conservative management, venous thrombectomy is a lifesaving treatment.

UI MeSH Term Description Entries
D008297 Male Males
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013924 Thrombophlebitis Inflammation of a vein associated with a blood clot (THROMBUS). Phlegmasia Alba Dolens,Dolens, Phlegmasia Alba,Thrombophlebitides

Related Publications

H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
June 2015, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
January 1984, Schweizerische Rundschau fur Medizin Praxis = Revue suisse de medecine Praxis,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
April 1970, Nordisk medicin,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
January 1990, Phlebologie,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
January 1990, World journal of surgery,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
December 1991, Revue medicale de la Suisse romande,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
January 1970, Phlebologie,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
May 1976, Minerva chirurgica,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
July 2002, Swiss medical weekly,
H W Kniemeyer, and K Grabitz, and R Buhl, and H J Wüst, and W Sandmann
March 1985, Minerva medica,
Copied contents to your clipboard!